Cocrystal Pharma, Inc. (COCP)
0.97
-0.04
(-3.96%)
USD |
NASDAQ |
Nov 18, 16:00
0.97
0.00 (0.00%)
After-Hours: 18:03
Cocrystal Pharma Price : 0.97 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 0.96 | 1.03 | 0.955 | 1.01 | 40564.00 |
| Nov 16, 2026 | 1.00 | 1.01 | 0.9599 | 0.9777 | 31251.00 |
| Nov 13, 2026 | 1.02 | 1.03 | 0.9801 | 0.9801 | 12132.00 |
| Nov 12, 2026 | 0.9894 | 1.040 | 0.9894 | 0.99 | 22477.00 |
| Nov 11, 2026 | 1.025 | 1.05 | 1.00 | 1.02 | 23640.00 |
| Nov 10, 2026 | 1.06 | 1.110 | 1.02 | 1.03 | 33049.00 |
| Nov 09, 2026 | 1.04 | 1.14 | 0.9901 | 1.105 | 62169.00 |
| Nov 06, 2026 | 0.98 | 1.04 | 0.98 | 1.04 | 26564.00 |
| Nov 05, 2026 | 1.040 | 1.04 | 0.9875 | 1.00 | 50584.00 |
| Nov 04, 2026 | 1.07 | 1.088 | 1.01 | 1.01 | 22815.00 |
| Nov 03, 2026 | 1.03 | 1.10 | 1.03 | 1.07 | 27876.00 |
| Nov 02, 2026 | 1.03 | 1.09 | 1.01 | 1.06 | 14926.00 |
| Oct 30, 2026 | 0.95 | 1.01 | 0.95 | 0.995 | 62764.00 |
| Oct 29, 2026 | 0.9701 | 0.98 | 0.97 | 0.98 | 14735.00 |
| Oct 28, 2026 | 0.9809 | 1.00 | 0.9698 | 0.99 | 32735.00 |
| Oct 27, 2026 | 0.94 | 0.9999 | 0.94 | 0.9809 | 17481.00 |
| Oct 26, 2026 | 0.97 | 1.01 | 0.9601 | 0.9719 | 21940.00 |
| Oct 23, 2026 | 0.92 | 1.07 | 0.92 | 0.95 | 43537.00 |
| Oct 22, 2026 | 0.9393 | 0.9998 | 0.912 | 0.912 | 17116.00 |
| Oct 21, 2026 | 0.9745 | 0.9745 | 0.927 | 0.9436 | 7548.00 |
| Oct 20, 2026 | 0.9145 | 0.976 | 0.9101 | 0.9429 | 15344.00 |
| Oct 19, 2026 | 1.01 | 1.016 | 0.91 | 0.9466 | 152285.0 |
| Oct 16, 2026 | 1.04 | 1.060 | 1.01 | 1.02 | 22975.00 |
| Oct 15, 2026 | 1.02 | 1.06 | 1.01 | 1.03 | 45597.00 |
| Oct 14, 2026 | 1.05 | 1.080 | 1.04 | 1.04 | 47810.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.77 |
| Fulcrum Therapeutics, Inc. | 3.725 |
| Definium Therapeutics, Inc. | 29.12 |
Price Related Metrics
| PS Ratio | 32.77 |
| Price to Book Value | 6.986 |
| Earnings Yield | -79.38% |
| Market Cap | 18.69M |